Dr. Xuan Cao is a Baltimore, Maryland based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Xuan Cao is D98025 for Ophthalmology in Maryland. Dr. Xuan Cao is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Xuan Cao speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
201 N Broadway St Bldg Floor9, Baltimore, Maryland, 21287-0031
Phone:
410-502-1262
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1386139673
NPI Enumeration Date:
28 Jun, 2018
NPI Last Update On:
20 Nov, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Xuan Cao are as mentioned below.
License Number
Specialization
State
Status
D98025
Ophthalmology
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6201 Greenleigh Ave, Middle River, Maryland
Zip:
21220-2004
Phone Number:
410-933-2704
Fax Number:
--
Patients can reach Dr. Xuan Cao at 201 N Broadway St Bldg Floor9, Baltimore, Maryland or can call to book an appointment on 410-502-1262. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.